Drug Profile
Research programme: viral vaccines - Virionics
Alternative Names: EbolaVax; RetroVaxLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Virionics
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ebola virus infections; HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Ebola-virus-infections in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections(Prevention) in USA